These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 3632000)

  • 1. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients.
    Revuz J; Penso D; Roujeau JC; Guillaume JC; Payne CR; Wechsler J; Touraine R
    Arch Dermatol; 1987 Sep; 123(9):1160-5. PubMed ID: 3632000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decade of burn unit experience with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Clinical pathological diagnosis and risk factor awareness.
    Lim VM; Do A; Berger TG; Nguyen AH; DeWeese J; Malone JD; Jordan K; Hom F; Tuffanelli L; Fillari P; Siu S; Grossman R
    Burns; 2016 Jun; 42(4):836-43. PubMed ID: 26847613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Toxic epidermal necrolysis (drug-induced Lyell's syndrome). I. Clinical features and differential diagnosis].
    Konstantinow A; Mühlbauer W; Balda BR; Ring J
    Dtsch Med Wochenschr; 2001 Feb; 126(6):141-4. PubMed ID: 11233882
    [No Abstract]   [Full Text] [Related]  

  • 4. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
    Roujeau JC
    Rev Prat; 2007 Jun; 57(11):1165-70. PubMed ID: 17691257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS; Huang FC; Tseng SH; Hsu CK; Ho CL; Sheu HM
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ocular sequelae and sicca syndrome following Lyell's syndrome].
    Roujeau JC; Phlippoteau C; Koso M; Wechsler J; Binaghi M; Revuz J; Touraine R
    Ann Dermatol Venereol; 1985; 112(11):883-8. PubMed ID: 3879142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study.
    Auquier-Dunant A; Mockenhaupt M; Naldi L; Correia O; Schröder W; Roujeau JC;
    Arch Dermatol; 2002 Aug; 138(8):1019-24. PubMed ID: 12164739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcal scalded skin syndrome in an immunocompetent adult, clinically mimicking toxic epidermal necrolysis.
    Tseng HC; Wu WM; Lin SH
    J Dermatol; 2014 Sep; 41(9):853-4. PubMed ID: 25041582
    [No Abstract]   [Full Text] [Related]  

  • 11. Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment.
    Schwartz RA; McDonough PH; Lee BW
    J Am Acad Dermatol; 2013 Aug; 69(2):187.e1-16; quiz 203-4. PubMed ID: 23866879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Mockenhaupt M
    Expert Rev Clin Immunol; 2011 Nov; 7(6):803-13; quiz 814-5. PubMed ID: 22014021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxic epidermal necrolysis--a premature requiem?
    Lancet; 1990 Jul; 336(8709):218-9. PubMed ID: 1973776
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced toxic epidermal necrolysis. I. An overview.
    Lyell A
    Clin Dermatol; 1993; 11(4):491-2. PubMed ID: 8124637
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving mortality outcomes of Stevens Johnson syndrome/toxic epidermal necrolysis: A regional burns centre experience.
    Nizamoglu M; Ward JA; Frew Q; Gerrish H; Martin N; Shaw A; Barnes D; Shelly O; Philp B; El-Muttardi N; Dziewulski P
    Burns; 2018 May; 44(3):603-611. PubMed ID: 29029855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxic epidermal necrolysis in Stevens--Johnson syndrome.
    Assaad D; From L; Ricciatti D; Shapero H
    Can Med Assoc J; 1978 Jan; 118(2):154-6. PubMed ID: 757383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
    Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY
    J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation.
    de Prost N; Mekontso-Dessap A; Valeyrie-Allanore L; Van Nhieu JT; Duong TA; Chosidow O; Wolkenstein P; Brun-Buisson C; Maître B
    Crit Care Med; 2014 Jan; 42(1):118-28. PubMed ID: 23989174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.